Status:

COMPLETED

Effects of Pitavastatin on Insulin Sensitivity and Liver Fat

Lead Sponsor:

Massachusetts General Hospital

Conditions:

Obesity

Fatty Liver, Nonalcoholic

Eligibility:

MALE

40-65 years

Phase:

NA

Brief Summary

HMG co-A reductase inhibitors, commonly called statins, are an effective treatment for dyslipidemia and atherosclerotic heart disease with proven mortality benefit. While the lipid-lowering effects of...

Eligibility Criteria

Inclusion

  • Men age 40-65yo
  • BMI ≥ 27kg/m2 and waist circumference ≥102cm, high probability risk factors for NAFLD
  • At least one of the following indicating insulin resistance: Fasting glucose ≥100mg/dL and \<126mg/dL, HOMA-IR \>2.0, and/or 2 hour glucose ≥140mg/dL and \<200mg/dL following standard glucose tolerance test.
  • 10-year cardiovascular disease risk ≥5% by American Heart Association(AHA)/American College of Cardiology (ACC) Pooled Cohort Equations CV Risk Calculator or LDL ≥ 100mg/dL
  • No use of any statin within 1 year of study entry and not being actively considered for statin therapy by a treating provider.

Exclusion

  • Diagnosis of diabetes or use of anti-diabetic medications.
  • Use of erythromycin, rifampin, cyclosporin, colchicine, or gemfibrozil.
  • Use of statin therapy within 1 year prior to study entry as above. Use of any other lipid-modifying therapy (including fish oil, fibrates, niacin, gemfibrozil) within 6 months of study entry.
  • Contraindication to statin therapy.
  • Creatinine \> upper limit of normal or known renal disease
  • AST or ALT \> 3 times the upper limit of normal
  • hemoglobin \< 10g/dL
  • Contraindication to undergoing a magnetic resonance scan.
  • Atherosclerotic cardiovascular disease or low-density lipoprotein cholesterol (LDL-C) ≥ 190mg/dL.
  • Triglyceride ≥500mg/dL

Key Trial Info

Start Date :

March 2 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 30 2018

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT02290106

Start Date

March 2 2015

End Date

April 30 2018

Last Update

July 2 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114